Answers are grounded in this paper and cite their sources.
Few human diseases have been described that are due to a defect in phospholipid biosynthesis. Phospholipids are required for pro-viding the essential milieu of biological membranes and are impor- tant precursors of signaling molecules. One would anticipate that a null mutation in an enzyme required for the biosynthesis of a phospholipid would not be compatible with life, particularly if that mutation resulted in complete elimination of that phospholipid. However, for several of the major mammalian phospholipids ( e.g. phosphatidylcholine (PC), 1 phosphatidylethanolamine (PE), and phosphatidylserine (PS)) more than one biosynthetic pathway operates (1). Consequently, the possibility exists that humans might have deficiencies in phospholipid biosynthesis that would not be detectable if alternative enzymes that catalyzed the same reaction were active or if alternative pathways were available for making that phospholipid. In the last two decades, advances in gene targeting in mice have made it possible to determine whether or not a particular enzyme or protein is essential for mammalian life. This article will summarize the current state of knowledge about induced mutations in murine genes involved in phospholipid biosynthesis and intracellular transport. To date, gene-targeting experiments have revealed that mice can survive without certain phospholipid biosynthetic enzymes; in each case, an alternative pathway or enzyme exists for making that phospholipid.Themajorbiosynthetic routes for the biosynthesis of PC, PE, and PS were elucidated in the 1950s largely by Eugene Kennedy and co-workers (2). In subsequent decades, attempts were made
No takes yet. Share an insight, caveat, or question.
Vance et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: